Issue Date: January 20, 2014
RNA Drug Firms Attract Deals
Small companies developing RNA-based therapeutics are finding eager partners. In less than a week, Alnylam Pharmaceuticals, Santaris Pharma, and Moderna Therapeutics announced drug development agreements totaling more than $1 billion.
. . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society